PharMerica to Present at the UBS Global HealthCare Conference
Get Alerts PMC Hot Sheet
Join SI Premium – FREE
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, and oncology pharmacy services, today announced that Gregory Weishar, Chief Executive Officer, will make a presentation regarding the Company at the UBS Global HealthCare Conference in New York City on Wednesday, May 25, 2016, at 9:00 a.m. Eastern Daylight Time.
The Company also announced that a live broadcast of its conference presentation, as well as any written materials accompanying the presentation, will be available on the “Investors” tab of the Company’s website, www.pharmerica.com, under “Upcoming Events.” In addition, the webcast and written materials will be archived under “Past Events” on the Company’s website following the event.
About PharMerica
PharMerica Corporation is a leading provider of pharmacy services. PharMerica serves the long-term care, hospital pharmacy management services, specialty home infusion and oncology pharmacy markets. PharMerica operates 93 institutional pharmacies, 17 specialty home infusion pharmacies and 5 specialty oncology pharmacies in 45 states. PharMerica’s customers are institutional healthcare providers, such as skilled nursing facilities, assisted living facilities, hospitals, individuals receiving in-home care and patients with cancer.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160517005430/en/
PharMerica Corporation
David W. Froesel, Jr., 502-627-7950
Executive
Vice President, Chief Financial Officer and Treasurer
Source: PharMerica Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Does your immune system learn like AI?
- Geofought Launches G14, M5 and F8 High Power Electric Scooters, Empowering Global Riders
- Universe Pro Achieves Major U.S. SEC Form D Filing Milestone
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share